MODIFICATION
A -- BARDA Nonclinical Development Biological Network
- Notice Date
- 4/6/2022 12:15:14 PM
- Notice Type
- Solicitation
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- BARDA - ASPR / DAAPPO / BARDA DCMA WASHINGTON DC 20515 USA
- ZIP Code
- 20515
- Solicitation Number
- 75A50122R00008
- Response Due
- 5/20/2022 11:00:00 AM
- Archive Date
- 06/04/2022
- Point of Contact
- Andrew Sargeant, Phone: 202-868-0048, Jeffrey Brown, Phone: 202-730-8662
- E-Mail Address
-
andrew.sargeant@hhs.gov, jeffrey.brown@hhs.gov
(andrew.sargeant@hhs.gov, jeffrey.brown@hhs.gov)
- Description
- The Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary�for Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services, provides�an integrated, systematic approach to the development of the necessary�vaccines, drugs, therapies,�and diagnostic tools for public health medical emergencies such as chemical, biological, radiological,�and nuclear (CBRN) accidents, incidents and attacks, pandemic�influenza, and emerging infectious diseases. Together with�our industry partners, BARDA promotes the advanced development of medical� countermeasures�(MCM) to protect Americans and respond to 21st century health security threats. The Public�Health Emergency Medical Countermeasures Enterprise (PHEMCE) MCM Review (2010) recommended�that PHEMCE partners provide not only financial help to medical countermeasure developers�but also technical and regulatory assistance. BARDA�s Strategic Plan (2011) set a goal to provide�assistance to developers through core assistance programs in critical areas including nonclinical and clinical�services to obtain safety and efficacy data supporting MCM development. To meet the demands�for MCM development and support an ever-increasing need for nonclinical services including�those required to address 21st Century Threats and BARDA�s innovation activities, this solicitation�seeks to establish a Nonclinical Services Network of laboratories providing expertise, capacity, and�program management across three capability areas: Capability Area 1:�Animal Model Development and MCM Testing (Biological Agents) Capability Area 2:�Analytical Method Development, Qualification, Validation, and Testing Capability Area 3:�Safety and Toxicity Testing BARDA anticipates�awarding multiple IDIQ contracts that provide a guaranteed minimum award to the organizations�or consortiums that meet the overall qualifications needed to fulfill the technical requirements of this solicitation for each capability area. Sample Task Orders are provided in the RFP solely�to evaluate Offerors� responses and capabilities. Responses for Task Order Requests (RTORs)�for specific tasks will be issued after award of the Parent Contract. This IDIQ will be administered and used to support BARDA initiatives as necessary to help accomplish its mission.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/467e508aed1444fdbee698409a8a9a4e/view)
- Place of Performance
- Address: USA
- Country: USA
- Country: USA
- Record
- SN06290514-F 20220408/220406230102 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |